NCT06545552

Efficacy and Safety of a Dietary Supplement on Hair Growth and Hair Health in Female With Acute Telogen Effluvium

Clinical Evaluation of the Efficacy and Safety of a Dietary Supplement on Hair Growth and Hair Health in Female With Acute Telogen Effluvium : a Double-blind, Randomized, Placebo-controlled, Clinical Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 66 (actual)
• Sponsor: Activ'inside · Industry
• Sex: Female
• Age: 18 Years – 52 Years
• Healthy volunteers: Accepted

Summary

The study is aimed to assess the efficacy of a food supplement in reducing hair loss and accelerating the physiological growth in terms of elongation in female subjects showing acute telogen effluvium. Moreover, the efficacy of the product in increasing hair elasticity, thickness and brightness will be assess. In order to reach this goal a randomized, double-blind, placebo controlled, parallel group (2 arms), clinical trial is carried out on 66 healthy female subjects aged between 18 and 52 years old, showing acute telogen effluvium will be enrolled.

Conditions

• Telogen Effluvium
• Healthy

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	An oral formulation of green tea extract, bamboo shoot extract and selenium-enriched yeast	Hard shell capsule containing 280mg of the oral formulation
DIETARY_SUPPLEMENT	Placebo	Hard shell capsule containing maltodextrine

Timeline

• Start date: 2024-09-30
• Primary completion: 2025-01-24
• Completion: 2025-01-24
• First posted: 2024-08-09
• Last updated: 2025-06-05

Locations

1 site across 1 country: Italy